Both ECMR and EnNaC activation lead to reduced endothelial NO synthase (eNOS) activation and NO bioavailability in association with reduced insulin-mediated capillary recruitment, glucose uptake, and systemic and tissue insulin resistance (Fig. 2). The gene discussed is INS; the disease is Insulin resistance.